Table of Contents
Journal of Mycology
Volume 2014, Article ID 303491, 8 pages
http://dx.doi.org/10.1155/2014/303491
Research Article

Epidemiology and Virulence Determinants including Biofilm Profile of Candida Infections in an ICU in a Tertiary Hospital in India

1Department of Microbiology, Maulana Azad Medical College & Associated Lok Nayak Hospitals, New Delhi 110002, India
2Department of Anesthesiology, Maulana Azad Medical College & Associated Lok Nayak Hospitals, New Delhi 110002, India

Received 12 October 2013; Revised 5 December 2013; Accepted 5 December 2013; Published 12 January 2014

Academic Editor: Praveen Rao Juvvadi

Copyright © 2014 Ravinder Kaur et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Méan, O. Marchetti, and T. Calandra, “Bench-to-bedside review: Candida infections in the intensive care unit,” Critical Care, vol. 12, no. 1, article 204, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. J. E. Edwards Jr., “Invasive Candida infections: evolution of a fungal pathogen,” The New England Journal of Medicine, vol. 324, no. 15, pp. 1060–1062, 1991. View at Google Scholar · View at Scopus
  3. C. M. Beck-Sague and W. R. Jarvis, “Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980–1990,” Journal of Infectious Diseases, vol. 167, no. 5, pp. 1247–1251, 1993. View at Google Scholar · View at Scopus
  4. V. Mohandas and M. Ballal, “Biofilm as virulence marker in Candida isolated from blood,” World Journal of Medical Sciences, vol. 2, no. 1, pp. 46–48, 2007. View at Google Scholar
  5. J. H. Shin, S. J. Kee, M. G. Shin et al., “Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources,” Journal of Clinical Microbiology, vol. 40, no. 4, pp. 1244–1248, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Eggimann, J. Garbino, and D. Pittet, “Management of Candida species infections in critically ill patients,” The Lancet Infectious Diseases, vol. 3, no. 12, pp. 772–785, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. E. W. Koneman, S. D. Allen, W. M. Janda et al., “Mycology,” in Color Atlas and Textbook of Diagnostic Microbiology, pp. 983–1057, Lippincott Williams and Wilkins, Philadelphia, Pa, USA, 5th edition, 1997. View at Google Scholar
  8. Clinical and Laboratory Standards Institute, “Reference method for broth dilution antifungal susceptibility testing of yeasts, Approved Standard—third edition,” CLSI Document M27-A3, Clinical and Laboratory Standards Institute (CLSI), 2008. View at Google Scholar
  9. V. Mohandas and M. Ballal, “Proteinase and phospholipase activity as virulence factors in Candida species isolated from blood,” Revista Iberoamericana de Micologia, vol. 25, no. 4, pp. 208–210, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. H. Samaranayake, R. S. Dassanayake, J. A. M. S. Jayatilake et al., “Phospholipase B enzyme expression is not associated with other virulence attributes in Candida albicans isolates from patients with human immunodeficiency virus infection,” Journal of Medical Microbiology, vol. 54, no. 6, pp. 583–593, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. M. L. Branchini, M. A. Pfaller, J. Rhine-Chalberg, T. Frempong, and H. D. Isenberg, “Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis,” Journal of Clinical Microbiology, vol. 32, no. 2, pp. 452–456, 1994. View at Google Scholar · View at Scopus
  12. G. P. Dureja, “Nosocomial Infections in Intensive Care Unit: a study,” Hospital Today, vol. 11, pp. 695–699, 2001. View at Google Scholar
  13. J. Freeman and J. E. McGonan Jr., “Methodological issues in hospital epidemiology: rates, core finding and interpretation,” Reviews of Infectious Diseases, vol. 3, pp. 668–677, 1981. View at Google Scholar
  14. E. R. M. Sydnor and T. M. Perl, “Hospital epidemiology and infection control in acute-care settings,” Clinical Microbiology Reviews, vol. 24, no. 1, pp. 141–173, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. P. H. Chandrasekar, J. A. Kruse, and M. F. Mathews, “Nosocomial infection among patients in different types of intensive care units at a city hospital,” Critical Care Medicine, vol. 14, no. 5, pp. 508–510, 1986. View at Google Scholar · View at Scopus
  16. A. Chakrabarti, K. Singh, and S. Das, “Changing face of nosocomial Candidemia,” Indian Journal of Medical Microbiology, vol. 17, pp. 160–166, 1999. View at Google Scholar
  17. I. Xess, N. Jain, F. Hasan, P. Mandal, and U. Banerjee, “Epidemiology of candidemia in a tertiary care centre of North India: 5-year study,” Infection, vol. 35, no. 4, pp. 256–259, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. R. I. Singh, I. Xess, P. Mathur, B. Behera, B. Gupta, and M. C. Misra, “Epidemiology of candidaemia in critically ill trauma patients: experiences of a level I trauma centre in North India,” Journal of Medical Microbiology, vol. 60, no. 3, pp. 342–348, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. R. J. Kothavade, M. M. Kura, A. G. Valand, and M. H. Panthaki, “Candida tropicalis: its prevalence, pathogenicity and increasing resistance to fluconazole,” Journal of Medical Microbiology, vol. 59, no. 8, pp. 873–880, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Bassetti, E. Righi, A. Costa et al., “Epidemiological trends in nosocomial candidemia in intensive care,” BMC Infectious Diseases, vol. 6, article 21, 2006. View at Publisher · View at Google Scholar
  21. S. Giri and A. J. Kindo, “A review of Candida species causing blood stream infection,” International Journal of Medical Microbiology, vol. 30, no. 3, pp. 270–278, 2012. View at Google Scholar
  22. M. A. Pfaller, D. J. Diekema, D. L. Gibbs et al., “Results from the artemis disk global antifungal surveillance study, 1997 to 2007: a 10.5-year analysis of susceptibilities of candida species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion,” Journal of Clinical Microbiology, vol. 48, no. 4, pp. 1366–1377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. M. Punithavathy, K. Nalina, and T. Menon, “Antifungal susceptibility testing of Candida tropicalis biofilms against fluconazole using calorimetric indicator resazurin,” Indian Journal of Pathology and Microbiology, vol. 55, no. 1, pp. 72–74, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. S. C. Deorukhkar and S. Saini, “Species distribution and antifungal susceptibility profile of Candida species isolated from blood stream infections,” Journal of Evolution of Medical and Dental Sciences, vol. 1, no. 3, pp. 241–249, 2012. View at Google Scholar
  25. A. Kothari and V. Sagar, “Epidemiology of Candida bloodstream infections in a tertiary care institute in India,” Indian Journal of Medical Microbiology, vol. 27, no. 2, pp. 171–172, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. C. P. G. Kumar, T. Sundararajan, T. Menon, and M. Venkatadesikalu, “Candidosis in children with onco-hematological diseases in Chennai, South India,” Japanese Journal of Infectious Diseases, vol. 58, no. 4, pp. 218–221, 2005. View at Google Scholar · View at Scopus
  27. J. F. Ernst and A. Schmidt, Dimorphism in Human Pathogenic and A Pathogenic Yeasts, S. Karger AG, Basel, Switzerland, 2000.
  28. O. Abaci and A. Haliki-Uztan, “Investigation of the susceptibility of Candida species isolated from denture wearers to different antifungal antibiotics,” African Journal of Microbiology Research, vol. 5, no. 12, pp. 1398–1403, 2011. View at Google Scholar · View at Scopus
  29. V. Mohandas and M. Ballal, “Distribution of Candida Species in different clinical samples and their virulence: biofilm formation, proteinase and phospholipase production: a study on hospitalized patients in Southern India,” Journal of Global Infectious Diseases, vol. 3, no. 1, pp. 4–8, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. S. A. Al-Nedaithy, “Spectrum and proteinase production of yeasts causing vaginitis in Saudi Arabian women,” Medical Science Monitor, vol. 8, no. 7, pp. CR498–CR501, 2002. View at Google Scholar · View at Scopus
  31. M. F. Price, I. D. Wilkinson, and L. O. Gentry, “Plate method for detection of phospholipase activity in Candida albicans,” Sabouraudia Journal of Medical and Veterinary Mycology, vol. 20, no. 1, pp. 7–14, 1982. View at Google Scholar · View at Scopus
  32. T. Wu, L. P. Samaranayake, B. Y. Cao, and J. Wang, “In-vitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents,” Journal of Medical Microbiology, vol. 44, no. 4, pp. 311–316, 1996. View at Google Scholar · View at Scopus
  33. A. S. Ibrahim, F. Mirbod, S. G. Filler et al., “Evidence implicating phospholipase as a virulence factor of Candida albicans,” Infection and Immunity, vol. 63, no. 5, pp. 1993–1998, 1995. View at Google Scholar · View at Scopus
  34. M. Negri, M. Martins, M. Henriques, T. I. E. Svidzinski, J. Azeredo, and R. Oliveira, “Examination of potential virulence factors of Candida tropicalis clinical isolates from hospitalized patients,” Mycopathologia, vol. 169, no. 3, pp. 175–182, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. A. D. Júnior Jr., A. F. Silva, F. C. Rosa, S. G. Monteiro, P. de Maria Silva Figueiredo, and C. de Andrade Monteiro, “In vitro diferential activity of phospholipases and acid proteinases of clinical isolates of Candida,” Revista da Sociedade Brasileira de Medicina Tropical, vol. 44, no. 3, pp. 334–338, 2011. View at Publisher · View at Google Scholar · View at Scopus
  36. F. Hasan, I. Xess, X. Wang, N. Jain, and B. C. Fries, “Biofilm formation in clinical Candida isolates and its association with virulence,” Microbes and Infection, vol. 11, no. 8-9, pp. 753–761, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. A. K. Pathak, S. Sharma, and P. Shrivastva, “Multi-species biofilm of Candida albicans and non-Candida albicans Candida species on acrylic substrate,” Journal of Applied Oral Science, vol. 20, no. 1, pp. 70–75, 2012. View at Publisher · View at Google Scholar · View at Scopus
  38. A. Kumar, V. C. Thakur, S. Thakur et al., “Phenotypic characterization and in vitro examination of potential virulence factors of Candida species isolated from blood stream infection,” World Journal of Science and Technology, vol. 1, no. 10, pp. 38–42, 2011. View at Google Scholar
  39. S. P. Hawser and L. J. Douglas, “Biofilm formation by Candida species on the surface of catheter materials in vitro,” Infection and Immunity, vol. 62, no. 3, pp. 915–921, 1994. View at Google Scholar · View at Scopus